You are here

biosimilars

J&J takes Samsung Bioepis to court over claims Korean company breached Stelara biosim settlement

Fierce Pharma

Tue, 02/25/25 - 11:00 am

Samsung Bioepis

Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara

MSN/Reuters

Fri, 02/21/25 - 11:18 am

Teva Pharmaceutical

autoimmune disease

Crohn's Disease

ulcerative colitis

plaque psoriasis

First biosimilar fast-acting insulin reaches US market

Pharmaphorum

Tue, 02/18/25 - 09:47 am

With recent launches and more to come, Amgen's biosimilar business is trending up

Fierce Pharma

Thu, 02/6/25 - 11:43 am

Regeneron patents block biosimilar entry for Eylea

Patently-O

Thu, 01/30/25 - 11:26 pm

Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June

Fierce Pharma

Wed, 01/29/25 - 11:20 am

The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars

Drug Channels

Wed, 01/22/25 - 11:17 am

Express Scripts

Coherus, sharpening immuno-oncology focus, sells another biosimilar for over $500M

BioPharma Dive

Wed, 12/4/24 - 10:59 am

Coherus Biosciences

immuno-oncology

Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition

Forbes

Sun, 11/10/24 - 09:31 pm

Biosimilars Are Making Inroads In U.S., But It’s Still A Bumpy Ride

Forbes

Mon, 11/4/24 - 07:04 pm

Regeneron loses bid to block Amgen's Eylea biosimilar launch in US

Reuters

Tue, 10/22/24 - 11:30 pm

Inflation Reduction Act proves positive boost for biosimilars

Pharmaphorum

Thu, 10/10/24 - 09:49 am

Inflation Reduction Act

Teva and mAbxience partner to develop biosimilar candidate for oncology

Pharmaceutical Technology

Fri, 10/4/24 - 09:28 am

Teva Pharmaceutical

Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar

Fierce Pharma

Tue, 09/24/24 - 11:56 am

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year

AOL

Tue, 09/10/24 - 04:33 pm

Unitedhealth Group

Evernorth Will Offer a Private-Label Stelara Biosimilar in 2025

Managed Healthcare Executive

Thu, 09/5/24 - 10:32 pm

Evernorth Health

IRA biosimilar measure intended to boost uptake so far has 'limited' impact: report

Fierce Pharma

Fri, 08/30/24 - 11:25 am

Inflation Reduction Act

Patent thickets in federal government’s crosshairs as election 2024 looms

BioSpace

Wed, 08/28/24 - 11:57 am

patent thickets

2024 Presidential election

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

Reuters

Mon, 08/26/24 - 10:14 pm

GlycoNex reports positive results for denosumab biosimilar Phase I trial

Clinical Trials Arena

Tue, 08/20/24 - 10:31 am

clinical trials

Pages